We are introducing our patients at Tyjeski Family Chiropractic to the new Erchonia Cold Laser. Our chiropractic team at our Beaver Dam and Watertown locations is here to answer any questions you may have about this exciting technology. This is a new treatment approved by the FDA that combats both chronic and acute pain using the power of light.
In contrast to the high-power, high-heat lasers that are used in various surgical procedures, Erchonia lasers produce a low-level, or cold, output that has no thermal effect on the body’s tissue. Instead, the laser serves to stimulate biological function similar to photosynthesis in plants.
Dr. Jerry comments, “We know our patients will benefit from this exciting technology. Treating chronic pain noninvasively with low level lasers instead of prescription drugs or surgery is the future of healthcare. Combining this with highly researched Chiropractic adjustments can be life changing for our patients.”
This technology was highly researched by the Erchonia Corporation, a global leader in low level laser healthcare applications, and was the first to receive FDA market clearance for the treatment of chronic pain, proven through two double blind IRB studies.
Would Cold Laser therapy help me?
Cold Lasers have many applications and we are excited to introduce them to our patients.
One of the applications is the treatment of chronic pain. Dr. Jerry will be recommending this to patients to support the chiropractic adjustments. He will also be recommending this for acute injury treatments. Laser therapy helps reduce inflammation and aid in the healing of the tissue, muscles and ligaments associated with traumatic injuries.
There are many protocols for cold laser treatments. Just a few are plantar fasciitis, muscular-skeletal pain, shoulder/hand/knee/ankle pain or injuries and headache or TMJ pain.
Dr. Jerome and Cindy will be happy to answer all of your Cold Laser questions and concerns! Give our chiropractic team at Tyjeski Family Chiropractic in Beaver Dam and Watertown a call today.